So, What’s Your Plan?

Diagnosis identifies disease. Assessment reveals support needs. Planning directs individualized action. Outcomes determine success.

A diagnosis of Alzheimer's disease initiates a series of clinical decisions. Assessment may identify declining executive function, unreliable medication management, changing driving safety, communication needs, increased caregiver support requirements, or an emerging mismatch between environmental demands and current functional capacity. Each finding provides clinically meaningful information about the individual.

The subsequent clinical responsibility is to determine how those findings should systematically direct individualized action.

This is the function of planning.

Planning translates assessment findings into coordinated decisions regarding intervention, accommodation, environmental modification, communication support, risk mitigation, caregiver response, and ongoing monitoring. It establishes what should occur, who should be involved, which strategies should be implemented consistently, and what indicators should prompt reassessment.

Yet within Alzheimer's care, this translation is often fragmented.

Assessment findings may be documented across neurology notes, neuropsychological evaluations, occupational or physical therapy assessments, nursing documentation, social work recommendations, and caregiver reports. Each discipline contributes clinically meaningful information. However, the existence of multidisciplinary information does not inherently produce an integrated plan.

Documentation records what has been observed. Planning directs what should happen next.

They are not interchangeable.

Across healthcare, individualized planning is an expected component of complex clinical care. Diagnosis informs treatment. Assessment findings influence intervention. Identified risks alter recommendations. Response to intervention informs subsequent clinical decisions.

Outcomes then provide evidence regarding whether the selected interventions are achieving their intended purpose. Preserved independence, improved safety, reduced distress, sustained participation, decreased caregiver support requirements, or delayed functional decline may each provide clinically meaningful evidence of effectiveness.

• The process is sequential, but also dynamic.

• Assessment informs planning.

• Planning directs action.

• Outcomes inform reassessment.

As clinical presentation changes, the process repeats.

Yet in Alzheimer's care, the burden of translating fragmented clinical findings into an operational system of everyday support frequently falls to families.

A spouse may learn that executive functioning is declining. A daughter may be told her father's judgment is impaired. A family may be advised that independent medication management is no longer safe. Each receives clinically important information, but information alone does not establish a coordinated approach to care.

Families must still determine which medications require supervision, which tasks should remain independent, what environmental modifications are appropriate, which communication strategies should be used consistently, and which changes require immediate intervention rather than continued monitoring. They must often distinguish progressive functional decline from transient distress, unmet physiological needs, environmental mismatch, or ineffective support strategies.

These are not diagnostic questions.

They are planning decisions.

The distinction is clinically significant because person-centered care requires more than recognition of individual differences. It requires a process capable of responding to those differences through individualized action.

Two individuals may both have Alzheimer's disease. One may retain strong verbal communication while experiencing significant impairment in task sequencing. Another may independently complete familiar routines but demonstrate impaired judgment in unfamiliar environments. One may experience distress primarily during transitions, while another becomes overwhelmed when environmental stimulation exceeds current processing capacity.

Their diagnosis may be identical, yet their functional presentations, preserved abilities, risks, environments, caregiver resources, and support needs may differ substantially.

Assessment reveals those differences.

Planning must respond to them.

What abilities remain intact and should be intentionally preserved? Where is support currently required? Which environmental conditions contribute to distress? Which communication approaches remain effective? What accommodations reduce functional barriers? Which risks require immediate intervention? What indicators should trigger reassessment?

The answers to these questions should inform more than isolated recommendations. Collectively, they should direct a coordinated, individualized approach to care.

This is where the gap becomes increasingly difficult to ignore.

Alzheimer's care has become increasingly precise in identifying the disease. Functional assessment can provide increasingly detailed information regarding how an individual is currently experiencing that disease.

But between assessment and implementation lies a critical clinical function:

Planning.

The goal is not simply to understand Alzheimer's.

The goal is to understand the person well enough to individualize their care.

Person-centered care cannot end with understanding the person.

It must systematically change what we do.

Diagnosis identifies disease. Assessment reveals support needs. Planning directs individualized action. Outcomes determine success.

Next in this series...

We know individualized planning matters.

What if Alzheimer's care had a structured process for doing it?